Capecitabine as Second-Line Treatment for Metastatic Cholangiocarcinoma: A Report of Two Cases

Publisher： Karger

E-ISSN： 2296-5262|25|2|182-184

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.25, Iss.2, 2002-05, pp. : 182-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful TS‐1 monotherapy as the second‐line treatment for advanced extramammary Paget's disease: A report of two cases

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 1, 2018-01 ,pp. : 80-82

John Wiley & Sons Inc

Access to resources Recommend Favorite

Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers

By  

Oncology, Vol. 76, Iss. 4, 2009-02 ,pp. : 254-261

Karger

Access to resources Recommend Favorite

Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 8-14

Karger

Access to resources Recommend Favorite

Modified CAPOX (Capecitabine plus Oxaliplatin) Regimen Every Two Weeks as Second-Line Treatment in Patients with Advanced Colorectal Cancer Previously Treated with Irinotecan-Based Frontline Therapy

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 31-36

Karger

Access to resources Recommend Favorite

Irinotecan in Second-Line Therapy of Metastatic Colorectal Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 4, 2000-05 ,pp. : 15-17

Karger

Access to resources Recommend Favorite